Control group | GES group | p | |
---|---|---|---|
Anterior tumors | |||
Mean ± SD BMI (kg/m2) | 25.1 ± 2.5 | 24.9 ± 3.4 | 0.80 |
Mean ± SD Console time (mins) | 125 ± 43 | 92 ± 36 | < 0.01 |
Mean ± SD DT (mins) | 100 ± 41 | 69 ± 35 | < 0.01 |
Mean ± SD WIT (mins) | 22.0 ± 4.9 | 20.3 ± 4.3 | 0.18 |
Mean ± SD EBL (ml) | 69 ± 48 | 66 ± 33 | 0.77 |
Mean ± SD tumor diameter (mm) | 38 ± 12 | 36 ± 10 | 0.39 |
Mean ± SD R.E.N.A.L. score | 7.6 ± 1.7 | 7.5 ± 1.6 | 0.83 |
Mean ± SD MAP score | 2.1 ± 1.6 | 2.2 ± 1.4 | 0.86 |
Posterior tumors | |||
Mean ± SD BMI (kg/m2) | 25.2 ± 3.2 | 23.7 ± 3.9 | 0.14 |
Mean ± SD Console time (mins) | 107 ± 36 | 90 ± 37 | 0.12 |
Mean ± SD DT (mins) | 84 ± 34 | 66 ± 35 | 0.04 |
Mean ± SD WIT (mins) | 20.5 ± 5.2 | 20.9 ± 4.1 | 0.73 |
Mean ± SD EBL (ml) | 93 ± 123 | 71 ± 52 | 0.62 |
Mean ± SD tumor diameter (mm) | 32 ± 11 | 40 ± 10 | 0.01 |
Mean ± SD R.E.N.A.L. score | 7.1 ± 1.9 | 7.3 ± 1.9 | 0.63 |
Mean ± SD MAP score | 1.7 ± 1.6 | 2.2 ± 1.3 | 0.17 |